Prediction: New Reason Lilly Stock Could Still Rise
Eli Lilly stock could advance in the second half of 2026 as Foundayo gains traction and the GLP-1 franchise shines, b...
Understanding TR indices helps investors gauge real performance by including income. This primer covers definitions, uses, and limitations for smarter choices.
27,608 articlesEli Lilly stock could advance in the second half of 2026 as Foundayo gains traction and the GLP-1 franchise shines, b...
PayPal sits near $42 after a tough year, sparking a lively debate on whether the stock is a bargain or a trap as Q4 r...
XPeng reported a rare quarterly profit in Q4 2025 but warned of a softer start to 2026, sending shares lower as inves...
Oracle's backlog surge and accelerating AI infrastructure growth are fueling a heated debate on whether the stock is ...
Nvidia announces a breakthrough that isn’t a chip, signaling a new era for AI infrastructure. Investors react as data...
Two dividend ETFs quietly beating SCHD on total return since early 2022 have captured investor interest as market con...
IonQ is set to report Q4 2025 earnings tonight, confronting a valuation that many analysts say risks outpacing the co...
With megacap dominance fading, traders are rethinking how to beat without magnificent risk. Equal-weight strategies a...
Silver prices climb in 2026, lifting pure-play silver miners trading below $30. Investors weigh the appeal of physica...
A sharp selloff in optical interconnect makers hits Applied Optoelectronics as it plunges 13%, prompting questions ab...
New data shows ULTY's steep cost, via a 1.24% expense ratio, quietly chewing into returns even as distributions persi...
Oracle defies the mood of a bruised AI rally, with Jefferies sticking to a buy and highlighting accelerating cloud gr...